Ira Longini has COVID-19’s number
Infectious disease modeler and biostatistician Ira Longini is applying decades of experience to help design and analyze clinical trials to identify a safe and effective COVID-19 vaccine.
Infectious disease modeler and biostatistician Ira Longini is applying decades of experience to help design and analyze clinical trials to identify a safe and effective COVID-19 vaccine.
Which global distribution strategy for a hypothetical COVID-19 vaccine will save the most lives?
The WHO Solidarity Trial will test multiple vaccines at possibly hundreds of sites in tens of thousands of participants to find vaccines with at least 50% efficacy.
The program trains doctoral students to become independent researchers in Parkinson’s disease, dystonia, tremor and ataxia.
Drs. Natalie Dean and Michelle Cardel share what they’ve learned about diversifying science conversations in the news and social media.
A new model by Dr. Ira Longini shows how Floridians' mobility and close contact has changed these past few months.
A new model shows that robust testing, contact tracing and household quarantining could offset a second pandemic wave once social distancing rules are relaxed.
The award is one of the university’s top honors for a junior faculty member.
Researchers propose a core protocol for conducting clinical trials during a disease outbreak.
Dr. Ira Longini and colleagues found that the Wuhan travel ban may have only delayed the epidemic’s spread by three to five days in mainland China.